Biocon Biologics
Arindam Saha is a highly experienced professional in the field of biomedical science, currently serving as Project Group Leader and Principal Scientific Manager at Biocon Biologics since January 2021. Prior to this, Arindam held various scientific roles at Biocon from May 2015 to December 2020, where responsibilities included Senior Scientific Manager, Scientific Manager, and Associate Scientific Manager II. Arindam's academic background includes a Ph.D. in Biochemistry and Gastroenterology from the Medical University of South Carolina, as well as Master's and Bachelor's degrees in Biochemistry and Chemistry from the University of Calcutta. Earlier research at the University of California, San Diego focused on the role of nutrient stress in tumor regression, alongside part-time teaching as an Assistant Professor at Sammilani Mahavidyalaya from September 2003 to June 2004.
This person is not in any teams
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics